These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15537355)

  • 21. Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
    Wei ZL; Petukhov PA; Xiao Y; Tückmantel W; George C; Kellar KJ; Kozikowski AP
    J Med Chem; 2003 Mar; 46(6):921-4. PubMed ID: 12620069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
    Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
    Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
    Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphiceptin analogues containing a dipeptide mimetic structure: an investigation on the bioactive topology at the mu-receptor.
    Grieco P; Giusti L; Carotenuto A; Campiglia P; Calderone V; Lama T; Gomez-Monterrey I; Tartaro G; Mazzoni MR; Novellino E
    J Med Chem; 2005 May; 48(9):3153-63. PubMed ID: 15857121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonists.
    Roumelioti P; Tselios T; Alexopoulos K; Mavromoustakos T; Kolocouris A; Moore GJ; Matsoukas JM
    Bioorg Med Chem Lett; 2000 Apr; 10(8):755-8. PubMed ID: 10782679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
    Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
    J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
    Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
    J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereospecific synthesis of a carbene-generating angiotensin II analogue for comparative photoaffinity labeling: improved incorporation and absence of methionine selectivity.
    Fillion D; Deraët M; Holleran BJ; Escher E
    J Med Chem; 2006 Apr; 49(7):2200-9. PubMed ID: 16570916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
    Lukaszuk A; Demaegdt H; Feytens D; Vanderheyden P; Vauquelin G; Tourwé D
    J Med Chem; 2009 Sep; 52(18):5612-8. PubMed ID: 19757839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of peptidomimetics based on substituted bicyclic 2-pyridones-targeting virulence of uropathogenic E. coli.
    Berg V; Sellstedt M; Hedenström M; Pinkner JS; Hultgren SJ; Almqvist F
    Bioorg Med Chem; 2006 Nov; 14(22):7563-81. PubMed ID: 16904898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability.
    Tourwé D; Tsiailanis AD; Parisis N; Hirmiz B; Del Borgo M; Aguilar MI; Van der Poorten O; Ballet S; Widdop RE; Tzakos AG
    Bioorg Med Chem Lett; 2021 Jul; 43():128086. PubMed ID: 33965531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
    Cappelli A; Nannicini C; Gallelli A; Giuliani G; Valenti S; Mohr Gl; Anzini M; Mennuni L; Ferrari F; Caselli G; Giordani A; Peris W; Makovec F; Giorgi G; Vomero S
    J Med Chem; 2008 Apr; 51(7):2137-46. PubMed ID: 18318468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.
    Turner RJ; Matsoukas JM; Moore GJ
    Biochim Biophys Acta; 1991 May; 1065(1):21-8. PubMed ID: 2043649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site.
    Ciuffo GM; Saavedra JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1129-34. PubMed ID: 7562479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-function relationship studies of PTH(1-11) analogues containing sterically hindered dipeptide mimetics.
    Fiori N; Caporale A; Schievano E; Mammi S; Geyer A; Tremmel P; Wittelsberger A; Woznica I; Chorev M; Peggion E
    J Pept Sci; 2007 Aug; 13(8):504-12. PubMed ID: 17617795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): clustering of the aromatic rings in dimethylsulfoxide.
    Matsoukas JM; Bigam G; Zhou N; Moore GJ
    Peptides; 1990; 11(2):359-66. PubMed ID: 2356159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure.
    Zhou HB; Comninos JS; Stossi F; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2005 Nov; 48(23):7261-74. PubMed ID: 16279785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of [alpha-methyltyrosine-4]angiotensin II: studies of its conformation, pressor activity, and mode of enzymatic degradation.
    Khosla MC; Stachowiak K; Smeby RR; Bumpus FM; Piriou F; Lintner K; Fermandjian S
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):757-60. PubMed ID: 6940144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.